To include your compound in the COVID-19 Resource Center, submit it here.

TB's links to TNF inhibitors

The European Medicines Evaluation Agency has issued recommendations for the use of Centocor Inc.'s Remicade infliximab in patients with Crohn's disease and rheumatoid arthritis (RA), following 28 worldwide reports of serious tuberculosis (TB) infections in patients treated with infliximab (see BioCentury Extra, Tuesday

Read the full 430 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers